Ascendis Pharma A/S (ASND) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 1.12B | 1.11B | 1.02B | 952.96M | 921.49M | 1.06B | 973.74M | 627.32M | 664.11M | 702.72M | 732.92M | 677.68M |
| Cash & Short-Term Investments | 573.42M | 615.78M | 539.09M | 494.05M | 517.92M | 559.54M | 625.51M | 258.7M | 320.24M | 399.44M | 455.43M | 431.1M |
| Cash Only | 573.42M | 615.78M | 539.09M | 494.05M | 517.92M | 559.54M | 625.51M | 258.7M | 320.24M | 392.16M | 441.27M | 394.22M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.28M | 14.16M | 36.88M |
| Accounts Receivable | 196.81M | 157.63M | 147.25M | 110.45M | 66.69M | 166.28M | 33.1M | 49.16M | 41.09M | 35.87M | 26.79M | 20.21M |
| Days Sales Outstanding | 63.63 | 57.2 | 55.49 | 51 | 103.84 | 52.73 | 65.43 | 114.08 | 36.52 | 20.93 | 45.02 | 34.88 |
| Inventory | 314.67M | 301.4M | 302.02M | 303.38M | 293.07M | 295.61M | 265.43M | 251.2M | 232.68M | 208.93M | 189.13M | 167.92M |
| Days Inventory Outstanding | 1.28K | 1.02K | 1.25K | 862.99 | 1.51K | 1.84K | 2.12K | 1.92K | 2.65K | 941.1 | 2.22K | 1.12K |
| Other Current Assets | 3 | 0 | 0 | 10.77M | 10.14M | 11.16M | 17.25M | 31.52M | 27.6M | 19.9M | 23.24M | 15.49M |
| Total Non-Current Assets | 881.86M | 193.5M | 136.97M | 134.94M | 139.95M | 118.63M | 120.04M | 130.98M | 138.39M | 122.87M | 140.29M | 146.15M |
| Property, Plant & Equipment | 136.06M | 146.42M | 101.76M | 93.54M | 92.45M | 98.71M | 97.52M | 104.04M | 107.16M | 110.63M | 125.53M | 125.36M |
| Fixed Asset Turnover | 1.77x | 1.98x | 2.19x | 1.70x | 1.06x | 1.77x | 0.57x | 0.34x | 0.88x | 1.17x | 0.38x | 0.37x |
| Goodwill | 3.69M | 3.49M | 0 | 0 | 0 | 3.5M | 0 | 0 | 0 | 3.5M | 0 | 0 |
| Intangible Assets | 0 | 214.91K | 3.74M | 3.79M | 3.91M | 533K | 4.11M | 4.19M | 4.3M | 924K | 4.5M | 4.61M |
| Long-Term Investments | 50.98M | 43.38M | 28.3M | 34.9M | 40.94M | 13.57M | 16.21M | 20.56M | 24.8M | 5.69M | 8.12M | 14.11M |
| Other Non-Current Assets | 0 | 0 | 3.16M | 2.71M | 2.66M | 2.32M | 2.2M | 2.19M | 2.13M | 2.13M | 2.14M | 2.07M |
| Total Assets | 2.01B | 1.3B | 1.15B | 1.09B | 1.06B | 1.18B | 1.09B | 758.3M | 802.5M | 825.59M | 873.21M | 823.82M |
| Asset Turnover | 0.15x | 0.20x | 0.19x | 0.15x | 0.09x | 0.15x | 0.06x | 0.05x | 0.12x | 0.16x | 0.06x | 0.05x |
| Asset Growth % | 88.93% | 10.39% | 5.57% | 43.47% | 32.27% | 42.87% | 25.26% | -7.95% | -16.95% | -24.24% | -31.43% | -37.91% |
| Total Current Liabilities | 1.13B | 1.07B | 986.48M | 935M | 885.51M | 907.86M | 838.46M | 847.74M | 798.97M | 736.51M | 212.76M | 192.27M |
| Accounts Payable | 78.67M | 90.62M | 78.6M | 93.72M | 84.37M | 96.39M | 75.27M | 99.53M | 94.53M | 94.57M | 121.55M | 122.12M |
| Days Payables Outstanding | 352.28 | 286.21 | 354.6 | 257.67 | 464.37 | 563.11 | 717.84 | 770.12 | 1.14K | 510.94 | 1.52K | 892.33 |
| Short-Term Debt | 511.09M | 486.32M | 482.28M | 462.35M | 489.96M | 491.54M | 449.73M | 453.59M | 439.39M | 421.27M | 11.82M | 26.56M |
| Deferred Revenue (Current) | 5.37M | 4.94M | 4.16M | 1.79M | 1.19M | 936K | 1.59M | 1.29M | 1.18M | 1.18M | 4.03M | 4.15M |
| Other Current Liabilities | 524.99M | 480.63M | 419.83M | 376.43M | 308.42M | 317.77M | 310.86M | 292.24M | 260.54M | 203.02M | 54.44M | 33.67M |
| Current Ratio | 1.00x | 1.04x | 1.03x | 1.02x | 1.04x | 1.17x | 1.16x | 0.74x | 0.83x | 0.95x | 3.44x | 3.52x |
| Quick Ratio | 0.72x | 0.76x | 0.73x | 0.69x | 0.71x | 0.84x | 0.84x | 0.44x | 0.54x | 0.67x | 2.56x | 2.65x |
| Cash Conversion Cycle | 993.37 | 791.59 | 946.69 | 656.32 | 1.15K | 1.33K | 1.47K | 1.26K | 1.55K | 451.09 | 750.95 | 264.37 |
| Total Non-Current Liabilities | 388.95M | 395.83M | 342.34M | 340.47M | 365.74M | 377.34M | 352.65M | 231.7M | 241.71M | 234.78M | 733.89M | 566.71M |
| Long-Term Debt | 386.51M | 385.09M | 331.37M | 330.19M | 357.31M | 365.08M | 338.93M | 219.05M | 229.63M | 223M | 549.48M | 479.37M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 84.62M | 90.1M | 0 |
| Deferred Tax Liabilities | 0 | 9.62M | 10.28M | 9.6M | 7.73M | 7.26M | 8.72M | 7.64M | 7.08M | 5.83M | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -84.62M | 93.35M | 86.39M |
| Total Liabilities | 1.52B | 1.46B | 1.33B | 1.28B | 1.25B | 1.29B | 1.19B | 1.08B | 1.04B | 971.28M | 946.65M | 758.98M |
| Total Debt | 897.6M | 871.41M | 813.65M | 792.53M | 847.27M | 856.62M | 788.66M | 672.64M | 669.01M | 743.06M | 665.84M | 505.94M |
| Net Debt | 324.18M | 255.64M | 274.56M | 298.49M | 329.35M | 297.07M | 163.15M | 413.94M | 348.77M | 350.89M | 224.57M | 111.72M |
| Debt / Equity | 1.84x | - | - | - | - | - | - | - | - | - | - | 7.80x |
| Debt / EBITDA | 30.42x | 59.76x | 54.19x | - | - | 176.33x | - | - | - | - | - | - |
| Net Debt / EBITDA | 10.99x | 17.53x | 18.28x | - | - | 61.15x | - | - | - | - | - | - |
| Interest Coverage | 0.37x | 0.16x | -2.91x | -0.06x | -1.09x | -0.75x | -2.87x | -4.56x | -0.67x | -1.06x | -5.59x | -12.06x |
| Total Equity | 488.48M | -162.75M | -174.07M | -187.57M | -189.81M | -105.71M | -97.32M | -321.13M | -238.18M | -145.7M | -73.43M | 64.84M |
| Equity Growth % | 357.36% | -53.97% | -78.87% | 41.59% | 20.31% | 27.45% | -32.53% | -595.26% | -242.45% | -155.32% | -116.26% | -89.33% |
| Book Value per Share | 7.57 | -2.65 | -2.85 | -2.93 | -3.16 | -1.77 | -1.66 | -5.60 | -4.19 | -2.57 | -1.30 | 1.15 |
| Total Shareholders' Equity | 488.48M | -162.75M | -174.07M | -187.57M | -189.81M | -105.71M | -97.32M | -321.13M | -238.18M | -145.7M | -73.43M | 64.84M |
| Common Stock | 8.39M | 8.32M | 8.28M | 8.21M | 8.19M | 8.15M | 8.14M | 7.82M | 7.82M | 7.75M | 7.74M | 7.7M |
| Retained Earnings | -2.09B | -2.7B | -2.71B | -2.67B | -2.66B | -2.56B | -2.55B | -2.47B | -2.39B | -2.28B | -2.2B | -2.06B |
| Treasury Stock | -35.04K | -79.97K | -80K | -80K | -80K | -113K | -118K | -118K | -118K | -146K | -149K | -149K |
| Accumulated OCI | 1.3M | -1.75M | -1.27M | 309K | 1.71M | 1.78M | 953K | 799K | 784K | 721K | 2.22M | 1.65M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |